Xickle® RBC-Plus™ is available now. WHY WAIT. Live a Healthier Life!
Connect With Us

The Links, Inc. Donates $1 Million to St. Jude for Sickle Cell Research

May 8, 2018 by Andrea
St. Jude

Photo by St. Jude Children's Research Hospital

Most of us know St. Jude Children's Research Hospital as the place that treats pediatric cancer patients at no charge to the family. But did you know the doctors at this hospital also treat kids with sickle cell (and other life-threatening diseases)? And they do it all through the donations they receive -- their latest from The Links Foundation, Inc. (the philanthropic segment of The Links, Inc., a nonprofit organization of professional Black women) of $1 million is designated specifically for sickle cell research. 

In a press release published on May 3, St. Jude reports that the donation called the Legacy Grant will go toward ensuring the progresson of three SCD programs: studies on how sickle cell affects cognitive abilities, a counseling initiative for parents of babies with sickle cell in Nigeria, and the development of a mobile app to help warriors practice self-care and disease literacy. "Advancing the care, and ultimately, the cure for sickle cell disease has been at the heart of St. Jude since the hospital opened," Dr. James R. Downing, president and CEO of the hospital said in the press release. 

This grant is somewhat of a full-circle moment for the research hospital, as the very first grant it ever received back in 1958 -- four years before the hospital was even built -- was also for sickle cell disease research. "St. Jude is an organization whose mission and vision align with ours ... and we greatly admire its deep and longstanding commitment to children with life-threatening diseases like sickle cell disease," Dr. Glenda Newell-Harris, president of The Links stated in the same release.

Find out more details here.

Sign Up For Xickle's Newsletter!

Get the latest news, health tips and special offers!

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!